Clinical trials

4

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Effect of Voiding Position (Standing in the Shower vs. Sitting) on Post-Void Residual Urine Volume (PVR) After Removal of Urinary Catheter in Women Following Benign Vaginal Gynecologic Surgery

The goal of this clinical trial is to learn if voiding in a standing position in the shower, rather than sitting on a toilet, may reduce pain associated with the act of voiding, thereby facilitating micturition and decreasing both post-void residual volume and the risk of subsequent urinary retention in women that underwent benign vaginal surgeries.

Participants needed: 100
Trial details
Age: 18-99Biological sex: FemaleType: InterventionalSponsor: Assuta Ashdod HospitalUpdated: Mar 25, 2026Locations: 2
Eligibility criteria

Adult women (≥18 years old). [+5]

Bladder injury during surgery. [+3]

Status: Recruiting

Screening for Fibromyalgia Among Patients With Suspected Endometriosis

The main purposes of the study are: To determine the prevalence of fibromyalgia among patients with suspected endometriosis during their initial visit to an endometriosis clinic. Secondary aims include staging of endometriosis in these patients according to the AAGL (16,17) endometriosis classification and correlate the prevalence of fibromyalgia with ultrasound and surgical findings. Another aim will be to assess the improvement in symptoms in patients diagnosed with both disorders in comparison to patients with either one separately. All women with suspected endometriosis will be asked to complete the questionnaire before their first visit to the doctor's office. Study design * A single center prospective cohort study * All patients attending to Endometriosis clinic at Assuta Ashdod University Hospital with suspected endometriosis at initial visit and who will consent and able to sign the consent form for participation. * Fibromyalgia will be defined by the ACR Preliminary Diagnostic Criteria, including Widespread Pain Index, Symptoms severity scale and somatic symptoms. * The treating physician will blinded to questionnaire results until the end of the visit. * At the end of the visit the questionnaire will be analyzed by one of the investigators and if fibromyalgia is found, the patient will also be referred for treatment of this disorder along with the endometriosis treatment. * Questionnaires will be coded with numbers from 1 to 150.

Participants needed: 150
Trial details
Biological sex: FemaleType: ObservationalSponsor: Assuta Ashdod HospitalUpdated: Jun 25, 2025Locations: 1
Eligibility criteria

All women with suspected endometriosis in their first visit to endometriosis cli...

Proven fibromyalgia prior to the first visit.

Status: Not yet recruiting

Oxytocin Effectiveness in First Trimester Dilatation and Curettage

The aim of this study is to investigate the impact of oxytocin on perioperative blood loss during the D\&C procedure, as well as to assess early and late complications associated with it's use.

Participants needed: 160
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: Assuta Ashdod HospitalUpdated: Aug 13, 2024
Eligibility criteria

All patients admitted to the OBGYN Assuta Ashdod Hospital for elective surgical...

individual intolerance to oxytocin [+4]

Status: Not yet recruiting

Use of Misoprostol in Hysteroscopic Myomectomy

Hysteroscopic myomectomy is typically suitable for myomas measuring under 4 cm in size. The utilization of misoprostol before the procedure can facilitate uterine access, decrease fluid absorption, and reduce blood loss, consequently leading to a decrease in the overall procedure time. In this randomized trial, the investigators aim to investigate the impact of misoprostol administration and its effects on each of the mentioned parameters.

Participants needed: 200
Trial details
Phase: Phase 4Age: 20-55Biological sex: FemaleType: InterventionalSponsor: Assuta Ashdod HospitalUpdated: Sep 22, 2023Locations: 1
Eligibility criteria

women between the ags of 20 years- 55 years, inclusive [+4]

post menopausal women [+6]